Nature Clinical Practice Rheumatology

Titel Veröffentlichungsdatum Sprache Zitate
CD4+CD25+FoxP3+ regulatory T cells in autoimmune diseases2007/11/01English112
Potential new drug targets for osteoporosis2009/01/01English109
Mechanisms of Disease: the role of immune cells in the pathogenesis of systemic sclerosis2006/12/01English108
Prospects for disease modification in osteoarthritis2006/06/01English106
Drug Insight: the mechanism of action of rituximab in autoimmune disease—the immune complex decoy hypothesis2007/02/01English105
Cryopyrinopathies: update on pathogenesis and treatment2008/07/29English101
Primer: epigenetics of autoimmunity2007/09/01English98
The effect of melanism and vitamin D synthesis on the incidence of autoimmune disease2009/02/01English97
Tobacco smoking and autoimmune rheumatic diseases2007/12/01English95
Mechanisms of Disease: the complement system and the pathogenesis of systemic lupus erythematosus2006/06/01English95
A case of macrophage activation syndrome successfully treated with anakinra2008/09/30English92
Systemic juvenile idiopathic arthritis: diagnosis, management, and outcome2006/01/01English91
Cytokine networks—towards new therapies for rheumatoid arthritis2005/11/01English91
Mode of action of hydroxychloroquine in RA—evidence of an inhibitory effect on toll-like receptor signaling2006/09/01English91
Chronic recurrent multifocal osteomyelitis: what is it and how should it be treated?2007/12/01English89
MicroRNAs, the immune system and rheumatic disease2008/08/26English88
New insights into the pathogenesis and genetics of psoriatic arthritis2009/02/01English87
Cognitive behavioral therapy for fibromyalgia2006/08/01English81
Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: rationale and mechanisms of action2007/05/01English81
Drug Insight: resistance to methotrexate and other disease-modifying antirheumatic drugs—from bench to bedside2007/01/01English80
Angiogenesis inhibition as a therapeutic approach for inflammatory synovitis2007/08/01English79
B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus2006/01/01English78
Risk factors and prognostic factors of hip and knee osteoarthritis2007/02/01English78
Mechanisms of Disease: molecular insights into aseptic loosening of orthopedic implants2007/03/01English73
Mechanisms of Disease: signaling pathways and immunobiology of inflammatory myopathies2006/04/01English71
Drug Insight: aggrecanases as therapeutic targets for osteoarthritis2008/06/24English71
The management of Sjögren's syndrome2006/05/01English71
A review of work-participation, cost-of-illness and cost-effectiveness studies in ankylosing spondylitis2006/10/01English70
Primer: Toll-like receptor signaling pathways—what do rheumatologists need to know?2008/04/29English68
Mechanisms of Disease: autoantigens as clues to the pathogenesis of myositis2008/03/04English67